NCT05171127View on ClinicalTrials.gov

Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument

CompletedOBSERVATIONAL

Enrollment

31

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

GlioblastomaSurgical Margin

Interventions

PROCEDURE

Diffuse Reflectance Spectroscopy

Measurements of DRS patterns in extirpated tumor and cerebral tissue

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

Sponsors

Collaborators (1)

Philips Healthcare

All Listed Sponsors

collaborator

Philips Healthcare

INDUSTRY

lead

Karolinska University Hospital

OTHER

NCT05171127 - Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument | Biotech Hunter | Biotech Hunter